Entering GSK, Alphalife Sciences Supports Pharmaceutical Companies in Embracing AI.
Nov 23, 2023
In the generative AI surge, global pharma explores AI for innovation. Join Sharon Chen and Bogong Zhu at CMAC to discuss AI's impact on clinical research.
In the surge of generative AI, global pharmaceutical companies are actively exploring how to leverage AI to accelerate medical innovation and clinical trial processes. In this CMAC Clinical Research Informatization Club event at GSK industry colleagues will delve into 'The Latest Developments in Large Language Models in China' and 'Exploration of AI Applications in Pharmaceutical and Vaccine Development in China'.
Ms. Sharon Chen, CEO of Alphalife Sciences and Chairperson of the CMAC Clinical Research Informatization Club, is invited as an honorary guest to share her profound insights on how generative AI can assist enterprises in transforming clinical informatization. Additionally, Bogong Zhu, Chief Product Officer of Alphalife Sciences and a seasoned AI product expert, is also invited to participate in this event on AI and Pharmaceutical Innovation. Let's explore the endless possibilities of AI together and move towards a smarter and more efficient new era of clinical research
